Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan

Chen, KY; Lee, KY; Qin, A; Luo, CS; Yeh, YK; Zheng, JQ; Chen, CM; Tsai, CY; Lin, S; Liao, J; Huang, YW; Feng, PH

Feng, PH (通讯作者),Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.

ADVANCES IN THERAPY, 2022; 39 (2): 910

Abstract

Introduction This study, for the first time to our knowledge, evaluated the efficacy of ropeginterferon alfa-2b, a long-acting pegylated interferon (I......

Full Text Link